This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Eli Lilly and Company.Clinical Data Suggest Potential Versatility of ALIMTA(R) (Pemetrexed for Injection)-Based Regimens in Lung Cancer. Media Release: 2 Jun 2007. Available from: URL: http://www.lilly.com
About this article
Cite this article
Pemetrexed-based chemotherapy provides QOL benefits similar to gemcitabine-based chemotherapy in patients with non-small cell lung cancer (NSCLC),. Pharmacoecon. Outcomes News 530, 10 (2007). https://doi.org/10.2165/00151234-200705300-00032
- Lung Cancer
- Health Outcome